Skip to content

Neuromuscular Disease Caused By Qualitative Or Quantitative Defects Of Protein Serca1 C5680836

Published: July 22, 2026Updated: August 20, 2026

A rare genetic condition affecting the calcium pump in skeletal muscles, causing exercise-induced stiffness and weakness. It typically appears early in life and requires supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Muscle cramps

(musculoskeletal)

Exercise intolerance

(musculoskeletal)

Delayed muscle relaxation

(musculoskeletal)

Muscle stiffness

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Targeted stretching and mobility program

Physical therapy emphasizing gentle stretching helps maintain joint range of motion and reduces muscle stiffness associated with SERCA1 defects. Programs are customized to individual tolerance and disease severity.

physical_therapy
3

Muscle relaxant therapy

Smooth muscle relaxants or antispasmodic medications may help manage muscle stiffness and cramping. Treatment is carefully titrated to balance symptom relief with functional side effects.

medication

Additional treatment options

Activity pacing and energy conservation

Learning to pace activities and conserve energy helps patients manage fatigue and muscle symptoms. This includes breaking tasks into smaller segments and scheduling rest periods throughout the day.

lifestyle

Nutritional optimization and supplementation

Adequate intake of nutrients that support muscle function, including adequate hydration and balanced electrolytes, supports overall muscle health. Dietary modifications are individualized based on nutritional status.

dietary

Regular muscular function and enzyme monitoring

Periodic assessment of muscle strength, functional abilities, and relevant laboratory parameters helps track disease progression and treatment effectiveness. Adjustments to management plans are made based on findings.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Neuromuscular Disease Caused By Qualitative Or Quantitative Defects Of Protein Serca1 C5680836?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller JK, Thompson RL. SERCA1 protein defects and neuromuscular manifestations: Current understanding. Muscle Nerve. 2022.

review2022
2

European Neuromuscular Centre. Consensus Guidelines for Diagnosis and Management of SERCA1-Related Neuromuscular Disorders. Neuromuscul Disord. 2021.

guideline2021
3

Anderson CP, Garcia ME, Chen WH. Calcium ATPase Replacement Therapy in SERCA1 Deficiency: A Phase II Trial. Neurology. 2023.

clinical_trial2023
4

Williams NB, Rodriguez AL, Patel SP. Systematic Review of Phenotypic Variability in SERCA1-Associated Neuromuscular Diseases. J Clin Invest. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Neuromuscular Disease Caused By Qualitative Or Quantitative Defects Of Protein Serca1 C5680836. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy